Cell mechanisms underlying induction of apoptosis in human erythroleukaemic K562 cells line treated byquinoline-N-oxide derivatives

   
Volkova T.O.1 , Zykina N.S.1, Malycheva I.E.1, Nemova N.N.1

1. Department of Molecular Biology, Petrozavodsk State University
Section: Experimental/Clinical Study
PubMed Id: 16805390
Year: 2006  Volume: 52  Issue: 2  Pages: 180-187
We have studied the influence of 2-(4'-nitrostyryl)-quinoline-1-oxide (2-NSQO) and 4-(4'-nitrostyryl)-quinoline-1-oxide (4-NSQO) on modulation activity of microsomal NADPH-oxidoreductases, concentration of nicotinamide enzymes and induction of apoptosis in human erythroleukaemic K562 cells. It was shown, that activity of microsomal NADPH-cytochrome c-reductases in cancer cells was inhibited by 10 μM 4-NSQO (15%), and 10 μM 2-NSQO (50%). Treatment of cells with these reagents for two days, was accompanied by caspases-9 and -3 activation, rise of EtBr and DAPI fluorescence related to DNA binding and induction of apoptosis. Apoptosis was preceded by the decrease of concentration of nicotinamide enzymes. Thus 4-NSQO is a promising compound for further experimental trials as an anticancer drug with low toxic action on the tissues of organism.
Download PDF:  
Keywords: cancer cell lines, apoptosis, caspases, NADPH-dependent reductases, quinoline-N-oxide derivatives
Citation:

Volkova, T. O., Zykina, N. S., Malycheva, I. E., Nemova, N. N. (2006). Cell mechanisms underlying induction of apoptosis in human erythroleukaemic K562 cells line treated byquinoline-N-oxide derivatives. Biomeditsinskaya Khimiya, 52(2), 180-187.
This paper is also available as the English translation: 10.1134/S199075080701012X
References  
 2024 (vol 70)
 2023 (vol 69)
 2022 (vol 68)
 2021 (vol 67)
 2020 (vol 66)
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)